971 related articles for article (PubMed ID: 17020993)
21. Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinoma.
Favrot MC; Combaret V; Negrier S; Philip I; Thiesse P; Freydel C; Bijmann JT; Franks CR; Mercatello A; Philip T
J Biol Response Mod; 1990 Apr; 9(2):167-77. PubMed ID: 1971303
[TBL] [Abstract][Full Text] [Related]
22. IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma.
Frederiksen KS; Lundsgaard D; Freeman JA; Hughes SD; Holm TL; Skrumsager BK; Petri A; Hansen LT; McArthur GA; Davis ID; Skak K
Cancer Immunol Immunother; 2008 Oct; 57(10):1439-49. PubMed ID: 18286285
[TBL] [Abstract][Full Text] [Related]
23. Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage.
Mortarini R; Vegetti C; Molla A; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Anichini A
Clin Cancer Res; 2009 Jun; 15(12):4085-94. PubMed ID: 19509154
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo effects of zinc on cytokine signalling in human T cells.
Varin A; Larbi A; Dedoussis GV; Kanoni S; Jajte J; Rink L; Monti D; Malavolta M; Marcellini F; Mocchegiani E; Herbein G; Fulop T
Exp Gerontol; 2008 May; 43(5):472-82. PubMed ID: 18249079
[TBL] [Abstract][Full Text] [Related]
25. A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor.
McDermott DF; Trehu EG; Mier JW; Sorce D; Rand W; Ronayne L; Kappler K; Clancy M; Klempner M; Atkins MB
Clin Cancer Res; 1998 May; 4(5):1203-13. PubMed ID: 9607578
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma.
Hsueh EC; Famatiga E; Shu S; Ye X; Morton DL
Ann Surg Oncol; 2004 Oct; 11(10):892-9. PubMed ID: 15383418
[TBL] [Abstract][Full Text] [Related]
27. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
[TBL] [Abstract][Full Text] [Related]
28. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
Andersen MH; Gehl J; Reker S; Pedersen LØ; Becker JC; Geertsen P; thor Straten P
Semin Cancer Biol; 2003 Dec; 13(6):449-59. PubMed ID: 15001164
[TBL] [Abstract][Full Text] [Related]
29. Type 1 vs. type 2 cytokine secretion in vitro and its regulation by hydrocortisone in humans subjected to 120-day anti-orthostatic bed-rest regime.
Uchakin PN; Tobin BW; Morukov BV; Larina IV; Cubbage ML
J Gravit Physiol; 2002 Dec; 9(2):71-82. PubMed ID: 14638461
[TBL] [Abstract][Full Text] [Related]
30. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
31. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
[TBL] [Abstract][Full Text] [Related]
32. IL-12 receptor. II. Distribution and regulation of receptor expression.
Desai BB; Quinn PM; Wolitzky AG; Mongini PK; Chizzonite R; Gately MK
J Immunol; 1992 May; 148(10):3125-32. PubMed ID: 1578139
[TBL] [Abstract][Full Text] [Related]
33. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
[TBL] [Abstract][Full Text] [Related]
34. IL-6 activates STAT5 in T cells.
Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF
Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263
[TBL] [Abstract][Full Text] [Related]
35. Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1.
Hogg AE; Bowick GC; Herzog NK; Cloyd MW; Endsley JJ
J Leukoc Biol; 2009 Nov; 86(5):1191-203. PubMed ID: 19687290
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure.
Vredevoe DL; Widawski M; Fonarow GC; Hamilton M; Martínez-Maza O; Gage JR
Am J Cardiol; 2004 Apr; 93(8):1007-11. PubMed ID: 15081444
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma.
Manchanda P; Sharma SC; Das SN
Oral Dis; 2006 Sep; 12(5):455-62. PubMed ID: 16910915
[TBL] [Abstract][Full Text] [Related]
38. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells.
Ueda M; Imada K; Imura A; Koga H; Hishizawa M; Uchiyama T
Br J Haematol; 2005 Jan; 128(2):169-76. PubMed ID: 15638850
[TBL] [Abstract][Full Text] [Related]
39. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
[TBL] [Abstract][Full Text] [Related]
40. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.
Schmidt-Wolf IG; Finke S; Trojaneck B; Denkena A; Lefterova P; Schwella N; Heuft HG; Prange G; Korte M; Takeya M; Dorbic T; Neubauer A; Wittig B; Huhn D
Br J Cancer; 1999 Nov; 81(6):1009-16. PubMed ID: 10576658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]